Z

Zeiss

Corporate venture capital for deep-tech startups

Regional Business Development Manager

Full-TimeUpdated on 10/23/2026
No salary listed
Expert
Bachelor's
Québec City, QC, Canada
RemoteRemote work is listed for Quebec; applicants must live in Quebec.
Sales & Account ManagementBusiness Development & Partnerships

About the job

Requirements
  • At least 7 years of successful business-to-business sales experience, preferably in prescription sales, optical, medical device, or retail operations with Fortune 500 companies.
  • At least 2 years of prior management experience.
  • At least 2 years of business development experience.
  • A bachelor's degree in Business Administration or Marketing.
  • Strong sales focus and ability to move key opportunities through the sales cycle, providing detailed and accurate sales forecasts using Salesforce.
  • Business-fluent French at C1 level, including negotiation proficiency.
  • Must live in Quebec.
  • Must have a car and a valid driver's license.
  • Ability to create plans to achieve revenue and profitability goals.
  • Consultative, conceptual, and negotiation skills, with ability to establish influential customer relationships.
  • Ability to work with contracts and legal documents.
  • Disciplined, results-oriented approach to selling and strong time-management skills.
  • Ability to collaborate with and through others.
  • Ability to influence situations and people and work independently.
  • Leadership skills and ability to direct, coach, and motivate staff.
  • Understanding of client business dynamics and financials.
  • Excellent written and verbal communication skills.
  • Interpersonal, problem-solving, and analytical skills.
Responsibilities
  • Provide planning and direction to support strong employee and sales-agent working relationships, motivation, training, ongoing coaching, and guidance while promoting alignment with corporate policies and standards.
  • Conceptualize, recommend, and develop programs and plans to increase product penetration and meet sales objectives.
  • Develop, implement, and report on sales plans and programs to drive market penetration of ZEISS products in the Eye Care Professional marketplace.
  • Plan and conduct technical, sales, and business presentations at regional, provincial, and national conventions, seminars, trade shows, and other professional meetings.
  • Gather and analyze competitive data and communicate findings and recommendations to the Head of Sales.
  • Prepare sales forecasts and projections aligned with company objectives and strategic priorities.
  • Work with other Regional Business Development Managers to achieve sales objectives and share best practices.
  • Collaborate with relevant buying groups in the territory or region to support smooth operations and effective sales and marketing.
  • Work with Credit Services and Finance on customer financial status and sales data; with Marketing on customer programs and product launches; with Commercial Operations on sales-team support systems; with Rx Laboratories on partnerships; and with Customer Service to resolve customer issues.
  • Support Business Development Representatives and sales agents by building the knowledge, capabilities, and resources they need to meet agreed objectives.
  • Lead talent planning, including hiring, onboarding, training, and coaching, to build customer relationships and represent and sell ZEISS product lines effectively.
  • Help customers grow their businesses through sales leadership, market-development initiatives, and strategic engagement.
  • Prepare the sales team for and support execution of Quarterly Business Reviews as directed by the division Head of Sales.
  • Perform other responsibilities as assigned.
Desired Qualifications
  • Licensed optician.
  • Experience with Salesforce or another customer relationship management system.

About the company

ZEISS Ventures is the corporate venture capital arm of the ZEISS Group, investing in deep-tech startups in Information Technology, Industrial Tech, MedTech, and Life Sciences. It backs early-stage companies at pre-Series A to Series A with typical investments of $1–5 million. The fund provides capital and tailored funding solutions, leveraging ZEISS’s global network and optics/optoelectronics expertise to support portfolio companies. Its goal is to accelerate the development of new technologies and business models that complement ZEISS’s portfolio while actively engaging with external innovation.

Company Size

1,001-5,000

Company Stage

Growth Equity (Non-Venture Capital)

Total Funding

$67.7M

Headquarters

Oberkochen, Germany

Founded

2001

Get referred to Zeiss

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • First-half 2025/26 revenue reached €5.841 billion, with EBIT rising to €955 million.
  • ZEISS CLINIC 360 won FDA 510(k) clearance on August 19, 2026.
  • EURETINA 2026 launches expanded retina imaging, cataract systems, and DORC brand integration.

What critics are saying

  • ZEISS Meditec plans up to 1,000 cuts by 2029, signaling margin pressure.
  • Göttingen workers entered mediation in February 2026 after Zeiss targeted roughly 140 jobs.
  • ASML scanner timing controls ZEISS SMT revenue; any slip delays optics demand immediately.

What makes Zeiss unique

  • ZEISS supplies ASML's exclusive EUV optics, anchoring High-NA lithography through 2030.
  • ZEISS Medical Technology bundles imaging, software, and surgery across one ophthalmic workflow stack.
  • ZEISS CLINIC 360 and Collaborative Care tie devices, cloud analytics, and referrals together.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • 401(k) Retirement Plan
  • Paid Vacation
  • Performance Bonus

Company News

Associated Press
Oct 12th, 2026
ZEISS launches NLX X-ray inspection and DUNE wafer warpage correction for advanced chip packaging

ZEISS Semiconductor Manufacturing Technology (SMT) has launched two systems for advanced chip packaging: ZEISS NLX and ZEISS DUNE. The company announced them in San Francisco on October 12, 2026, as chips grow more complex. ZEISS NLX inspects the inside of chip packages without damaging them. It helps manufacturers spot defects in connections between stacked dies early, and it handles 300-millimetre wafers in both process development and high-volume production. ZEISS DUNE measures the topography of a wafer and corrects wafer bow individually. This helps avoid yield losses in downstream processing and prepares bonding processes. ZEISS SMT is showing the systems at SEMICON West, alongside its photomask tools. The company is also marking 100 years of business in the US in 2026.

PR Newswire
Sep 24th, 2026
ZEISS unveils retinal imaging and surgical innovations at EURETINA 2026

ZEISS Medical Technology has announced expansions to its ZEISS Retina Workflow at the EURETINA 2026 congress in Vienna. The company introduced the ZEISS ALTA DUO 300, combining OCT and fundus imaging in a single device for streamlined retinal diagnostics. ZEISS also unveiled the HMDmd CR3, a head-mounted 3D display that connects with the ZEISS ARTEVO 850 surgical microscope. The company reported that its DORC ILM-BLUE and DORC MEMBRANEBLUE-DUAL vitreoretinal surgical dyes reached a 3 million milestone. Additionally, ZEISS announced that the DORC brand will be consolidated under the ZEISS brand name, unifying the company's ophthalmic offerings. The DORC TDC VELOCE cutter continues to show improvements in 27G vitrectomy procedures, with clinical data suggesting up to 41% shorter core vitrectomy times.

PR Newswire
Sep 17th, 2026
ZEISS expands retinal imaging portfolio with new ALTA DUO 300 multimodal OCT device

ZEISS Medical Technology has expanded its retinal imaging portfolio with the launch of ZEISS ALTA DUO 300, a fully automated, compact multimodal imaging solution. The device combines optical coherence tomography (OCT) and fundus photography in a single unit, designed to provide efficient retinal assessment for eye care practices. The ALTA DUO 300 features four key diagnostic technologies: automated structural OCT with reference database and reporting, true colour fundus camera, AI-enhanced OCT-Angiography, and full chamber depth anterior OCT scanning. The device aims to integrate retinal imaging into everyday patient care through simplified workflows. The product will be showcased at the European Society of Retina Specialists congress in Vienna from 1-4 October and will be available in select markets later in 2026.

Yahoo Finance
Aug 27th, 2026
ZEISS launches DORC EVA NEXUS cataract system at ESCRS in London

ZEISS Medical Technology has launched a cataract-only configuration of its DORC EVA NEXUS ophthalmic surgical system. The system features a cataract grade selection with up to four programmable presets, allowing surgeons to optimise phaco, aspiration, and irrigation settings for each surgical step. The solution includes VacuFlow VTi pump, SMART IOP, and EVA EQUIPHACO technologies, designed to provide streamlined performance, stability, and control during procedures. It integrates with the ZEISS Cataract Workflow portfolio. The system debuted at the European Society of Cataract and Refractive Surgeons congress in London. It will become available in select European countries from September 2026, with global rollout pending regulatory approvals. The technology expands ZEISS's existing EVA NEXUS platform, which previously focused on retina workflows.

PR Newswire
Aug 19th, 2026
ZEISS CLINIC 360 receives FDA clearance for cloud-based ophthalmic data management software

ZEISS Medical Technology announced FDA 510(k) clearance for ZEISS CLINIC 360, a cloud-based software solution that aggregates ophthalmic clinical data and provides advanced analytics. The browser-based platform combines diagnostic and medical data into a comprehensive patient view, helping clinicians evaluate disease progression and support treatment decisions. The solution integrates data from DICOM-enabled diagnostic devices, including ZEISS's CIRRUS, CLARUS and HFA systems, as well as third-party devices. It features disease-based summaries, interactive analysis tools, and collaboration capabilities through ZEISS Collaborative Care. ZEISS CLINIC 360 will be available in the US in early autumn 2026 on a subscription basis with low upfront costs. The platform complements ZEISS FORUM, the company's on-premise data management system, giving providers flexibility in choosing their preferred infrastructure approach.